全文获取类型
收费全文 | 1076篇 |
免费 | 70篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 40篇 |
妇产科学 | 2篇 |
基础医学 | 81篇 |
口腔科学 | 17篇 |
临床医学 | 157篇 |
内科学 | 456篇 |
皮肤病学 | 23篇 |
神经病学 | 34篇 |
特种医学 | 124篇 |
外科学 | 95篇 |
综合类 | 17篇 |
预防医学 | 52篇 |
眼科学 | 1篇 |
药学 | 33篇 |
肿瘤学 | 33篇 |
出版年
2021年 | 16篇 |
2018年 | 6篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 14篇 |
2014年 | 25篇 |
2013年 | 33篇 |
2012年 | 18篇 |
2011年 | 30篇 |
2010年 | 44篇 |
2009年 | 51篇 |
2008年 | 29篇 |
2007年 | 38篇 |
2006年 | 35篇 |
2005年 | 31篇 |
2004年 | 26篇 |
2003年 | 21篇 |
2002年 | 27篇 |
2001年 | 26篇 |
2000年 | 24篇 |
1999年 | 27篇 |
1998年 | 41篇 |
1997年 | 40篇 |
1996年 | 32篇 |
1995年 | 33篇 |
1994年 | 15篇 |
1993年 | 22篇 |
1992年 | 15篇 |
1991年 | 28篇 |
1990年 | 27篇 |
1989年 | 25篇 |
1988年 | 33篇 |
1987年 | 35篇 |
1986年 | 23篇 |
1985年 | 28篇 |
1984年 | 18篇 |
1983年 | 24篇 |
1982年 | 21篇 |
1981年 | 14篇 |
1980年 | 18篇 |
1979年 | 9篇 |
1978年 | 15篇 |
1977年 | 13篇 |
1976年 | 13篇 |
1975年 | 14篇 |
1974年 | 17篇 |
1973年 | 10篇 |
1972年 | 7篇 |
1971年 | 5篇 |
1968年 | 5篇 |
排序方式: 共有1168条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Eric A Schwartz Peter D Reaven 《Endocrinology & Metabolism Clinics of North America》2006,35(3):525-49, viii
Although the prevalence of cardiovascular complications is increased in insulin-resistant individuals, the underlying causes of this link have been elusive. Recent work suggests that several intracellular signal transduction pathways are inappropriately activated by hyperinsulinemia, hyperglycemia, increased free fatty acids, dyslipidemia, various inflammatory cytokines and adipokines--factors that are increased in insulin resistance. Once activated, substantial cross talk occurs between these pathways, especially a self-reinforcing cascade of vascular inflammation and cell dysfunction, greatly increasing the risk and severity of atherosclerosis in the insulin-resistant individual. We review several key cell-signalling pathways, describe how they are activated in they insulin-resistant state and the damage they induce, and discusses possible therapeutic approaches to limit vascular damage. 相似文献
5.
M M Fuh C M Lee C Y Jeng D C Shen S M Shieh G M Reaven Y D Chen 《Kidney international》1990,37(5):1295-1300
Plasma lipid and lipoprotein concentration and high density lipoprotein (HDL) kinetics were determined in control subjects and patients with chronic renal failure (CRF). Results demonstrated that plasma triglyceride (TG) concentration was significantly higher (P less than 0.001) in patients with CRF, associated with a significant increase in plasma VLDL-cholesterol (P less than 0.002) and a significant decrease (P less than 0.05) in plasma HDL-cholesterol concentration. The rate of removal of 125I-apoAI/HDL from plasma was slower (P less than 0.001) in the patients with CRF, resulting in an increase in the residence time of 125I-apoAI/HDL (P less than 0.001) and a decrease in the fractional catabolic rate (P less than 0.001). Since plasma apoAI concentration was lower in patients with CRF, total apoAI/HDL synthetic rate was also significantly (P less than 0.05) decreased. These data provide support for the view that low plasma HDL-cholesterol concentrations in patients with CRF are related to decreases in the synthetic rate of apoAI/HDL. 相似文献
6.
Polycystic kidney disease is an autosomal dominant disease that may be associated with cystic disease of the liver. In women, the cysts may develop early and be more troublesome than in men. Cystadenocarcinoma of the pancreas is uncommon, comprising 1% of primary pancreatic malignancies. This case report is the first to describe a familial association between polycystic kidney disease and cystadenocarcinoma of the pancreas and liver in the English medical literature. A patient with autosomal dominant polycystic kidney disease (ADPKD) and multiple hepatic cysts developed cystadenocarcinoma of the pancreas with multiple malignant liver cysts. The patient's mother, sister, and niece had ADPKD, and the patient's sister also died of pancreatic cystadenocarcinoma. We believe that the development of these two disease entities in which the primary pathology is cyst formation has a genetic association. (Gastroenterology 1997 Jun;112(6):2104-7) 相似文献
7.
8.
9.
Annika?E?StenbergEmail author Lisskulla?Sylvén Carl?GM?Magnusson Malou?Hultcrantz 《Journal of negative results in biomedicine》2004,3(1):6
Disturbances in the immune system has been described in Turner syndrome, with an association to low levels of IgG and IgM
and decreased levels of T- and B-lymphocytes. Also different autoimmune diseases have been connected to Turner syndrome (45,
X), thyroiditis being the most common. 相似文献
10.
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy 总被引:3,自引:4,他引:3
Milasin J; Muntoni F; Severini GM; Bartoloni L; Vatta M; Krajinovic M; Mateddu A; Angelini C; Camerini F; Falaschi A; Mestroni L; Giacca M 《Human molecular genetics》1996,5(1):73-79
X-linked dilated cardiomyopathy (XLDC) is a familial heart disease
presenting in young males as a rapidly progressive congestive heart
failure, without clinical signs of skeletal myopathy. This condition has
recently been linked to the dystrophin gene in some families and deletions
encompassing the genomic region coding for the first muscle exon have been
detected. In order to identify the defect responsible for this disease at
the molecular level and to understand the reasons for the selective heart
involvement, a family with a severe form of XLDC was studied. In the
affected members, no deletions of the dystrophin gene were observed.
Analysis of the muscle promoter, first exon and intron regions revealed the
presence of a single point mutation at the first exon-intron boundary,
inactivating the universally conserved 5' splice site consensus sequence of
the first intron. This mutation introduced a new restriction site for MseI,
which cosegregates with the disease in the analyzed family. Expression of
the major dystrophin mRNA isoforms (from the muscle-, brain- and Purkinje
cell-promoters) was completely abolished in the myocardium, while the
brain- and Purkinje cell- (but not the muscle-) isoforms were detectable in
the skeletal muscle. Immunocytochemical studies with anti- dystrophin
antibodies showed that the protein was reduced in quantity but normally
distributed in the skeletal muscle, while it was undetectable in the
cardiac muscle. These findings indicate that expression of the muscle
dystrophin isoform is critical for myocardial function and suggest that
selective heart involvement in dystrophin- linked dilated cardiomyopathy is
related to the absence, in the heart, of a compensatory expression of
dystrophin from alternative promoters.
相似文献